Pages that link to "Q41140380"
Jump to navigation
Jump to search
The following pages link to Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy (Q41140380):
Displaying 28 items.
- The treatment of climacteric symptoms (Q26992273) (← links)
- Understanding the cognitive impact of the contraceptive estrogen Ethinyl Estradiol: tonic and cyclic administration impairs memory, and performance correlates with basal forebrain cholinergic system integrity (Q27304411) (← links)
- GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol (Q28280092) (← links)
- Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study (Q33525190) (← links)
- Micronized progesterone: clinical indications and comparison with current treatments (Q33750997) (← links)
- Use of androgens and oestrogens in adolescents--a review of hormone replacement treatment (Q33847078) (← links)
- Risk assessment of growth hormones and antimicrobial residues in meat (Q34388054) (← links)
- Transdermal patches: history, development and pharmacology. (Q35484265) (← links)
- GPR30 FORMS AN INTEGRAL PART OF E2-PROTECTIVE PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (Q35663947) (← links)
- Association of serum 17β-estradiol concentration, hormone therapy, and alveolar crest height in postmenopausal women (Q35747314) (← links)
- Randomized, Crossover and Single-Dose Bioquivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 μg) in Healthy Female Volunteers (Q36058603) (← links)
- Hormone replacement therapy in menopausal women: Past problems and future possibilities (Q36668526) (← links)
- The influence of oral contraceptives on athletic performance in female athletes (Q36862236) (← links)
- Self-assembling materials for therapeutic delivery (Q37310864) (← links)
- Oral contraceptives and the periodontium (Q38067475) (← links)
- Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities (Q40362575) (← links)
- Current state of hormone replacement therapy: the case for using trimegestone (Q43267040) (← links)
- A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers (Q43540311) (← links)
- The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy (Q44273785) (← links)
- Endogenous and exogenous female sex hormones and renal electrolyte handling: effects of an acute sodium load on plasma volume at rest (Q46626848) (← links)
- No Effect of Menstrual Cycle Phase and Oral Contraceptive Use on Endurance Performance in Rowers (Q51493443) (← links)
- Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24 4 cycle with desogestrel 75 μg per day. (Q53791853) (← links)
- Developments in contraception: a comprehensive review of Desogen (desogestrel and ethinyl estradiol). (Q55067677) (← links)
- Review of the effects of 17α-estradiol in humans: a less feminizing estrogen with neuroprotective potential (Q56031122) (← links)
- Oral combined contraception: is there any difference between ethinyl-estradiol and estradiol? (Q83241727) (← links)
- Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls (Q89587072) (← links)
- Examination of methods for manipulating serum 17β-Estradiol (E2) levels by analysis of blood E2 concentration in medaka (Oryzias latipes) (Q90124498) (← links)
- Inhibitory effects of 17-α-ethinyl-estradiol and 17-β-estradiol on transport via the intestinal proton-coupled amino acid transporter (PAT1) investigated in vitro and in vivo (Q98658069) (← links)